Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for the Management of Thromboembolic Disorders
Authors:
- Judy W.M. ChengJCJudy W.M. Cheng
- Huyen VuHVHuyen Vu
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 34 (4) , 766-787
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Prevention of VTE in Orthopedic Surgery PatientsChest, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Beyond Unfractionated Heparin and WarfarinCirculation, 2007
- Venous thromboembolismBMJ, 2006
- Direct Thrombin InhibitorsNew England Journal of Medicine, 2005
- Ximelagatran: An orally active direct thrombin inhibitorAmerican Journal of Health-System Pharmacy, 2005
- Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight HeparinAnnals of Pharmacotherapy, 2005
- Pulmonary embolismThe Lancet, 2004
- Direct Thrombin Inhibitors for AnticoagulationAnnals of Pharmacotherapy, 2004